カテゴリ： GlobalData, アメリカ, 企業調査

Medidata Solutions Inc (MDSO)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Medidata Solutions Inc (MDSO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7465
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：87
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. Medidata offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations (CROs). The company markets and sells its products through direct sales force, CROs and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc (MDSO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 6
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Medidata Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Medidata Solutions Inc, Medical Equipment, Deal Details 13
Venture Financing 13
Syapse Raises USD30 Million in Series D Financing 13
Shyft Analytics Raises USD12.5 Million in Series B Venture Financing 15
Partnerships 16
Quartesian Enters into Licensing Agreement with Medidata Solutions 16
Medidata Solutions and Decibel Therapeutics Enter into Agreement 17
Medidata Solutions and Syapse Enter into Partnership 18
Medidata Expands Partnership with CytomX Therapeutics 19
Medidata Solutions Expands its Agreement with BeiGene 20
Medidata Solutions and Karyopharm Therapeutics Expand Partnership 21
Medidata Solutions Enters into Agreement with Forty Seven 22
Medidata Solutions Enters into Agreement with Memorial Sloan Kettering Cancer Center 23
Medidata Solutions Partners with C&R Research 24
Auris Medical Enters Into Agreement With Medidata Solutions 25
Veeva Systems Enters Into Technology Integration Agreement With Medidata Solutions 26
Debt Offering 27
Medidata Solutions Completes Private Placement Of Notes Due 2018 For US$287.5 Million 27
Medidata Solutions Inc – Key Competitors 28
Medidata Solutions Inc – Key Employees 29
Medidata Solutions Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 32
Strategy And Business Planning 32
Feb 15, 2018: Medidata and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement to Adopt Medical Imaging and Workflow Solutions 32
Sep 27, 2017: Medidata Opens New, Larger London EMEA Headquarters 33
Jun 22, 2017: Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials 34
Mar 02, 2017: Medidata and INC Research Expand Technology Partnership 35
Financial Announcements 36
Jul 24, 2018: Medidata Reports Second Quarter 2018 Results 36
Apr 19, 2018: Medidata Announces First Quarter 2018 Results 38
Feb 08, 2018: Medidata Reports Record Full-Year and Fourth Quarter 2017 Results 39
Oct 26, 2017: Medidata Reports Record Third Quarter 2017 Results 41
Jul 18, 2017: Medidata Reports Record Second Quarter 2017 Results 43
Apr 26, 2017: Medidata Reports Record First Quarter 2017 Results 45
Feb 09, 2017: Medidata Reports Record Full-Year and Fourth Quarter 2016 Results 47
Research And Development 49
Feb 28, 2017: Medidata and Medical Device Innovation Consortium Partner to Help Drive Change in the Medical Technology Space 49
Corporate Communications 50
Jun 28, 2018: Medidata Appoints New China GM and Doubles Size of Talent in Region 50
Legal and Regulatory 51
May 08, 2018: Medidata Offers Breakthrough to De-Risk Clinical Trial Submissions 51
Government and Public Interest 52
Jul 26, 2018: Medidata corporate social responsibility initiatives benefit patients, students, and communities 52
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives 53
Oct 02, 2017: Industry Leaders Gather at Medidata NEXT Global 2017 to Discuss How Technology is Transforming Clinical Research 54
Product News 55
Jul 11, 2018: Medidata NEXT Seoul and Shanghai Events Host Industry Thought Leaders at the Forefront of the Digital Transformation in Life Sciences 55
Jun 25, 2018: Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata 56
May 21, 2018: Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation 57
Feb 12, 2018: Medidata Solutions to Host Annual European NEXT Conference Series 58
Nov 28, 2017: Medidata Presenting at the 2017 Partnerships in Clinical Trials Europe Conference 59
Nov 07, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials 60
Other Significant Developments 61
Oct 10, 2018: Medidata cloud securely manages echocardiogram images for global heart measurement study 61
Oct 04, 2018: Industry milestone: over 15,000 studies have run on Medidata cloud platform 62
May 23, 2018: Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata’s eClinical Platform 63
May 01, 2018: Idera Pharmaceuticals Increases Operational Efficiency of Global Oncology Program with Medidata Clinical Cloud 64
Feb 13, 2018: Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement 65
Feb 08, 2018: Medidata Ushers in Era of Choice as Life Science Companies Can Now Conduct Both Virtual and On-site Clinical Trials on One eClinical Platform 66
Feb 06, 2018: Medidata’s Next Generation Site Selection and Operational Benchmarking Tools Generally Available 67
Dec 05, 2017: Medidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content 68
Nov 20, 2017: Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research with Multi-Year Medidata eTMF Agreement 69
Nov 15, 2017: Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials 70
Nov 09, 2017: Medidata Introduces New Strategic Monitoring Suite to Ensure Sponsors and Sites Meet ICH E6 Guidelines 71
Oct 26, 2017: Horizon Pharma to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation 72
Oct 05, 2017: Neurological-Focused pharmaceutical company, Lundbeck, Continues Use of Medidata Clinical Cloud with Multi-Year Partnership 73
Jul 24, 2017: Medidata Expands Partnership with BeiGene to use Medidata’s Patient Cloud ePRO Solution 74
Jul 20, 2017: “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata 75
Jul 13, 2017: Medidata Successfully Hosts Annual European NEXT Conference Series 76
Jul 12, 2017: Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe 77
Jun 13, 2017: Chiltern and Medidata Mark 10-Year Anniversary Milestone in Bringing Cloud-based Technology to Clinical Development 78
May 24, 2017: CROS NT Announces Extended Partnership With Medidata — Deploys RaveX 79
May 15, 2017: Medytox to Further Expand Global Presence by Increasing Its Adoption of the Medidata Clinical Cloud 80
May 08, 2017: Medidata Introduces Regulated Content and Document Management Capabilities to Its Industry-Leading Cloud Platform 81
Apr 26, 2017: UCB Selects Medidata Clinical Cloud to Support Patient-Centric Drug Development 82
Apr 24, 2017: WuXi Clinical Development Services Expands Use of Medidata’s Cloud Technology Platform 83
Feb 01, 2017: Medidata to Expand Its Industry-Leading Cloud Platform with Regulated Content and Document Management Capabilities 84
Jan 31, 2017: Pharm-Olam International Deploys Medidata Rave; Shores up Global Data Management and Reporting Capabilities 85
Jan 12, 2017: Celgene Increases Adoption of Medidata Clinical Cloud, Gaining Further Value from Implementation of Medidata’s Strategic Monitoring and Data Analytics Solutions 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87

List of Tables
Medidata Solutions Inc, Medical Equipment, Key Facts, 2017 2
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Medidata Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Medidata Solutions Inc, Deals By Market, 2012 to YTD 2018 10
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Syapse Raises USD30 Million in Series D Financing 13
Shyft Analytics Raises USD12.5 Million in Series B Venture Financing 15
Quartesian Enters into Licensing Agreement with Medidata Solutions 16
Medidata Solutions and Decibel Therapeutics Enter into Agreement 17
Medidata Solutions and Syapse Enter into Partnership 18
Medidata Expands Partnership with CytomX Therapeutics 19
Medidata Solutions Expands its Agreement with BeiGene 20
Medidata Solutions and Karyopharm Therapeutics Expand Partnership 21
Medidata Solutions Enters into Agreement with Forty Seven 22
Medidata Solutions Enters into Agreement with Memorial Sloan Kettering Cancer Center 23
Medidata Solutions Partners with C&R Research 24
Auris Medical Enters Into Agreement With Medidata Solutions 25
Veeva Systems Enters Into Technology Integration Agreement With Medidata Solutions 26
Medidata Solutions Completes Private Placement Of Notes Due 2018 For US$287.5 Million 27
Medidata Solutions Inc, Key Competitors 28
Medidata Solutions Inc, Key Employees 29
Medidata Solutions Inc, Other Locations 30
Medidata Solutions Inc, Subsidiaries 31

List of Figures
Medidata Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Medidata Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Medidata Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Medidata Solutions Inc (MDSO)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Caterpillar Inc (CAT)-エネルギー分野：企業M&A・提携分析
    Summary Caterpillar Inc. (Caterpillar) is a manufacturer of construction, transportation and energy equipment. It designs, manufactures, markets and sells construction and mining equipment, industrial gas turbines, forestry machinery, diesel and natural gas engines, and diesel-electric locomotives. …
  • Young & Co.’s Brewery plc (YNGA)：企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AK Steel Holding Corp：企業の戦略・SWOT・財務情報
    AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report Summary AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sharp HealthCare：企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Guangzhou Improve Medical Instruments Co Ltd (300030)：医療機器：M&Aディール及び事業提携情報
    Summary Guangzhou Improve Medical Instruments Co Ltd (Improve Medical) is a medical devices company that offers medical products, technologies, and services for clinical laboratory and clinical nursing. The company’s products include Improvacuter evacuated blood collection systems, Impromini capilla …
  • First Solar Inc (FSLR)：電力：M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • Treatt Plc：企業の戦略・SWOT・財務情報
    Treatt Plc - Strategy, SWOT and Corporate Finance Report Summary Treatt Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ferrovial, S.A.：企業の戦略・SWOT・財務情報
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ThreeD Capital：企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Encavis AG (CAP)：企業の財務・戦略的SWOT分析
    Summary Encavis AG (Encavis), formally Capital Stage AG, is an independent power producer. It offer investment services such as asset sourcing, due diligence, management, and documentation of renewable energy assets. Encavis also provides technical services comprising monitoring, reporting, fault ma …
  • JPMorgan Chase & Co (JPM)：企業の財務・戦略的SWOT分析
    JPMorgan Chase & Co (JPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mentor Graphics Corp：企業の戦略的SWOT分析
    Mentor Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Genentech Inc：医療機器：M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • The Hain Celestial Group Inc (HAIN)：企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Concord New Energy Group Ltd (182)：企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Laboratorios LETI SL：企業の戦略的SWOT分析
    Laboratorios LETI SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary SM Energy Co (SM Energy) is an independent upstream oil and gas company. It carries out the acquisition, exploration, development, and production of crude oil, natural gas and natural gas liquids (NGLs) …
  • MORRE-TEC Industries, Inc.：企業の戦略・SWOT・財務情報
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Feintool International Holding AG (FTON)：企業の財務・戦略的SWOT分析
    Feintool International Holding AG (FTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Astex Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆